Dow Up 0.19% Nasdaq Up 0.26%

Gilead Sciences Inc. (GILD)

-NasdaqGS
110.25 Up 3.07(2.86%) 10:45AM EDT - Nasdaq Real Time Price
Prev Close:107.18
Open:107.34
Bid:109.95 x 400
Ask:109.98 x 100
1y Target Est:118.08
Beta:0.98
Next Earnings Date:28-Oct-14GILD Earnings announcement
Day's Range:106.60 - 110.90
52wk Range:63.50 - 110.90
Volume:5,552,702
Avg Vol (3m):14,383,700
Market Cap:166.66B
P/E (ttm):24.98
EPS (ttm):4.41
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Related Video

Comparison

Symbol% ChgMkt Cap
GILDUp 2.86%166.66B
GSKUp 0.60%109.60B
PFEUp 1.15%183.44B
RHHBYDown 0.55%247.67B

Key Statistics

Forward P/E (1 yr):11.39
P/S (ttm):9.29
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :8.05
Quarterly EPS Est (Sep-14) :1.92
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):0.58

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines for the treatment of life threatening diseases in North America, South America, Europe, and the Asia-Pacific. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback